Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study

Beth E. Snitz, Judith Saxton, Oscar L. Lopez, Diane G. Ives, Leslie O. Dunn, Stephen R. Rapp, Michelle C Carlson, Annette L. Fitzpatrick, Steven T. Dekosky

Research output: Contribution to journalArticle

Abstract

Objectives: To identify, characterize and compare the frequency of mild cognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. Method: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. Results: Overall, 15.7% of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0% vs. 5.7%). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1%. Conclusion: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.

Original languageEnglish (US)
Pages (from-to)171-182
Number of pages12
JournalAging and Mental Health
Volume13
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Ginkgo biloba
Dementia
Cognitive Dysfunction
Neuropsychological Tests
Consensus

Keywords

  • Dementia prevention trials
  • MCI
  • Neuropsychology

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Gerontology
  • Phychiatric Mental Health
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

Snitz, B. E., Saxton, J., Lopez, O. L., Ives, D. G., Dunn, L. O., Rapp, S. R., ... Dekosky, S. T. (2009). Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. Aging and Mental Health, 13(2), 171-182. https://doi.org/10.1080/13607860802380656

Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. / Snitz, Beth E.; Saxton, Judith; Lopez, Oscar L.; Ives, Diane G.; Dunn, Leslie O.; Rapp, Stephen R.; Carlson, Michelle C; Fitzpatrick, Annette L.; Dekosky, Steven T.

In: Aging and Mental Health, Vol. 13, No. 2, 03.2009, p. 171-182.

Research output: Contribution to journalArticle

Snitz, BE, Saxton, J, Lopez, OL, Ives, DG, Dunn, LO, Rapp, SR, Carlson, MC, Fitzpatrick, AL & Dekosky, ST 2009, 'Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study', Aging and Mental Health, vol. 13, no. 2, pp. 171-182. https://doi.org/10.1080/13607860802380656
Snitz, Beth E. ; Saxton, Judith ; Lopez, Oscar L. ; Ives, Diane G. ; Dunn, Leslie O. ; Rapp, Stephen R. ; Carlson, Michelle C ; Fitzpatrick, Annette L. ; Dekosky, Steven T. / Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study. In: Aging and Mental Health. 2009 ; Vol. 13, No. 2. pp. 171-182.
@article{497270af09f54e84bce765fa7758fcd8,
title = "Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study",
abstract = "Objectives: To identify, characterize and compare the frequency of mild cognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. Method: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. Results: Overall, 15.7{\%} of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0{\%} vs. 5.7{\%}). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1{\%}. Conclusion: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.",
keywords = "Dementia prevention trials, MCI, Neuropsychology",
author = "Snitz, {Beth E.} and Judith Saxton and Lopez, {Oscar L.} and Ives, {Diane G.} and Dunn, {Leslie O.} and Rapp, {Stephen R.} and Carlson, {Michelle C} and Fitzpatrick, {Annette L.} and Dekosky, {Steven T.}",
year = "2009",
month = "3",
doi = "10.1080/13607860802380656",
language = "English (US)",
volume = "13",
pages = "171--182",
journal = "Aging and Mental Health",
issn = "1360-7863",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study

AU - Snitz, Beth E.

AU - Saxton, Judith

AU - Lopez, Oscar L.

AU - Ives, Diane G.

AU - Dunn, Leslie O.

AU - Rapp, Stephen R.

AU - Carlson, Michelle C

AU - Fitzpatrick, Annette L.

AU - Dekosky, Steven T.

PY - 2009/3

Y1 - 2009/3

N2 - Objectives: To identify, characterize and compare the frequency of mild cognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. Method: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. Results: Overall, 15.7% of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0% vs. 5.7%). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1%. Conclusion: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.

AB - Objectives: To identify, characterize and compare the frequency of mild cognitive impairment (MCI) subtypes at baseline in a large, late-life cohort (n = 3063) recruited into a dementia prevention trial. Method: A retrospective, data-algorithmic approach was used to classify participants as cognitively normal or MCI with corresponding subtype (e.g. amnestic vs. non-amnestic, single domain vs. multiple domain) based on a comprehensive battery of neuropsychological test scores, with and without Clinical Dementia Rating (CDR) global score included in the algorithm. Results: Overall, 15.7% of cases (n = 480) were classified as MCI. Amnestic MCI was characterized as unilateral memory impairment (i.e. only verbal or only visual memory impaired) or bilateral memory impairment (i.e. both verbal and visual memory impaired). All forms of amnestic MCI were almost twice as frequent as non-amnestic MCI (10.0% vs. 5.7%). Removing the CDR = 0.5 ('questionable dementia') criterion resulted in a near doubling of the overall MCI frequency to 28.1%. Conclusion: Combining CDR and cognitive test data to classify participants as MCI resulted in overall MCI and amnestic MCI frequencies consistent with other large community-based studies, most of which relied on the 'gold standard' of individual case review and diagnostic consensus. The present data-driven approach may prove to be an effective alternative for use in future large-scale dementia prevention trials.

KW - Dementia prevention trials

KW - MCI

KW - Neuropsychology

UR - http://www.scopus.com/inward/record.url?scp=67949086828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67949086828&partnerID=8YFLogxK

U2 - 10.1080/13607860802380656

DO - 10.1080/13607860802380656

M3 - Article

VL - 13

SP - 171

EP - 182

JO - Aging and Mental Health

JF - Aging and Mental Health

SN - 1360-7863

IS - 2

ER -